David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFTX
1426
Definium Therapeutics
DFTX
$5.81B
| $14.8M | 0.01% |
315,410
+43,693
| +16% | +$1.08M |
|
1427
Prestige Consumer Healthcare
PBH
$2.46B
| $14.8M | 0.01% |
313,778
-67,255
| -18% | -$3.46M |
|
|
BCAX
1428
Bicara Therapeutics
BCAX
$1.56B
| $14.8M | 0.01% |
498,193
+221,250
| +80% | +$4.94M |
|
1429
Chubb
CB
$133B
| $14.8M | 0.01% |
43,383
+37,394
| +624% | +$12.2M |
|
1430
PUT
Humana
HUM
$46.4B
| $14.8M | 0.01% |
37,200
-62,700
| -63% | -$17.9M |
|
1431
Star Bulk Carriers
SBLK
$3.43B
| $14.8M | 0.01% |
591,314
-582,563
| -50% | -$15.1M |
|
1432
UGI
UGI
$8.19B
| $14.7M | 0.01% |
426,188
-81,945
| -16% | -$2.9M |
|
1433
CALL
Dave Inc
DAVE
$4.53B
| $14.7M | 0.01% |
39,500
+29,300
| +287% | +$7.62M |
|
1434
PUT
KKR & Co
KKR
$96.3B
| $14.7M | 0.01% |
160,100
+117,600
| +277% | +$11.4M |
|
1435
Antero Midstream
AM
$10.5B
| $14.7M | 0.01% |
644,890
+230,024
| +55% | +$5M |
|
1436
Burford Capital
BUR
$946M
| $14.7M | 0.01% |
3,577,247
+2,609,417
| +270% | +$11.9M |
|
1437
Westlake Corp
WLK
$9.78B
| $14.6M | 0.01% |
200,534
-32,649
| -14% | -$3.19M |
|
1438
Nutanix
NTNX
$18B
| $14.6M | 0.01% |
286,917
+259,283
| +938% | +$11.7M |
|
1439
Lamar Advertising Co
LAMR
$15.5B
| $14.6M | 0.01% |
93,715
+86,285
| +1,161% | +$12.5M |
|
|
IACO
1440
Idea Acquisition Corp
IACO
$437M
| $14.6M | 0.01% |
+1,472,601
| New | +$14.5M |
|
1441
Orion
OEC
$340M
| $14.5M | 0.01% |
2,194,308
-282,485
| -11% | -$2.03M |
|
1442
Affiliated Managers Group
AMG
$9.28B
| $14.5M | 0.01% |
42,839
+3,578
| +9% | +$1.11M |
|
1443
Wheaton Precious Metals
WPM
$72.8B
| $14.5M | 0.01% |
129,019
+115,767
| +874% | +$15.1M |
|
|
MOMO
1444
Hello Group
MOMO
$841M
| $14.5M | 0.01% |
2,496,180
-79,829
| -3% | -$476K |
|
1445
Colgate-Palmolive
CL
$73.8B
| $14.5M | 0.01% |
157,872
-321,478
| -67% | -$28.1M |
|
1446
ANI Pharmaceuticals
ANIP
$1.7B
| $14.5M | 0.01% |
174,732
-38,701
| -18% | -$3.1M |
|
|
BCAR
1447
D. Boral ARC Acquisition I Corp
BCAR
$228M
| $14.5M | 0.01% |
1,385,950
| – | – |
|
1448
Assured Guaranty
AGO
$3.26B
| $14.4M | 0.01% |
180,107
+48,148
| +36% | +$3.8M |
|
1449
Church & Dwight Co
CHD
$24.3B
| $14.4M | 0.01% |
148,791
-611,921
| -80% | -$58.5M |
|
|
ETOR
1450
CALL
eToro Group
ETOR
$2.31B
| $14.4M | 0.01% |
365,200
+130,200
| +55% | +$4.9M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.